growth rate

(redirected from Growth rates)
Also found in: Dictionary, Thesaurus, Medical, Financial.
Related to Growth rates: Economic Growth Rates, GDP Growth Rates

growth rate

[′grōth ‚rāt]
(microbiology)
Increase in the number of bacteria in a population per unit time.

growth rate

Rate of wood growth expressed as the number of annual rings per inch measured from pith to bark; sometimes used to rate soft-woods for strength.
References in periodicals archive ?
The astonishing growth rates and adoption rates in countries like Laos, Thailand, Uganda, Cambodia, and Ghana are good examples of once nascent markets that became vibrant revenue opportunities for suppliers in just the last two years, literally overnight in the context of a learning technology product lifecycle," adds Adkins.
The growth rates of some states like Bihar, Assam, Uttar Pradesh are still very low even during the period of 1990-91 to 2004-05.
According to the Statistical Service's Flash Estimate released in May, the GDP growth rate in real terms during the first quarter of 2012 would be -1.
Table 4 provides some sample statistics for the three growth rates ([lambda] for the loss ratio, [lambda] for premium, and [delta] for claims) by line of business.
Attention must now be given to the growth rates of 24 emerging economies.
The most simple price-to-dividend ratio depends on the real interest rate and the growth rate of dividends.
At present, Ihinger and Zink can obtain only relative growth rates.
If we remove the recovery years from the picture, the economy's real growth rate for the remainder of the Roaring Twenties was 3.
When asked to project one year ahead to June 1993, their growth rates bounce back to 26.
The two groups had annual average growth rates of 7.
Although the production of materials is more cyclical than that of products, from 1954 to 1980 their overall growth rates were similar.
However, behind this industry average figure there are strategic segments of the market that offer double-digit growth rates through barriers against generic competition and the opportunity for aggressive indication broadening.